Portfolio company
Depomed
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This pharmaceutical company develops and markets branded prescription medicines for patients with neurology, oncology, and inflammatory conditions.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Pharmacyclics
This company develops small-molecule medicines for patients with cancer and immune-mediated diseases.
Biohaven
This biopharmaceutical company develops therapeutics for patients with debilitating neurological, neuroinflammatory, and metabolic diseases, as well as immunological and oncology disorders.
Mecox Curemed
This pharmaceutical company develops drug delivery systems and oncology treatments for healthcare providers and patients through platform-based drug development.
Pharmasset
This biopharma company develops medicines for patients suffering from HIV, viral hepatitis, cancer, and inflammatory diseases.
Chimerix
This biopharmaceutical company develops medicines for oncology and viral diseases for patients with life-threatening conditions.
Dermira
This biopharmaceutical company develops and commercialises medical dermatology treatments for patients with chronic skin conditions such as excessive sweating and atopic dermatitis.
Eli Lilly
This pharmaceutical company develops and sells prescription medicines for patients with conditions including diabetes, obesity, cancer, immunology disorders and neurological diseases.
Tanabe Pharma
This pharmaceutical company develops and manufactures prescription medicines for patients with central nervous system disorders, autoimmune diseases, diabetes, and kidney conditions.
